SperdutoPW, MeskoS, LiJ, et al.Survival in patients with brain metastases: Summary report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility Quotient. J Clin Oncol, 2020; 38(32):3773–3784.
2.
MeyersDS. Palliative radiation therapy for the hospice patient: Nuances of care and reimbursement. J Oncol Pract, 2015; 11(1):e87–e88.
3.
RobinTP, RusthovenCG. Strategies to preserve cognition in patients with brain metastases: A review. Front Oncol, 2018; 8:415.
4.
YamamotoM, SerizawaT, ShutoT, et al.Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): A multi-institutional prospective observational study. Lancet Oncol, 2014; 15:387–395.
5.
YamamotoM, SerizawaT, HiguchiY, et al.A Multi-institutional prospective observational study of stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901 Study Update): Irradiation-related complications and long-term maintenance of mini-mental state examination scores. Int J Radiat Oncol Biol Phys, 2017; 99:31–40.
6.
AroraRD, AgarwalMS, MaaniEV, et al.Palliative Radiation Therapy for Brain Metastases. In: StatPearls. StatPearls Publishing: Treasure Island, FL; 2022. Tsao MN, Xu W, Wong RK, et al. Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases. Cochrane Database Syst Rev, 2018; 1(1):CD003869.
7.
KhanM, LinJ, LiaoG, et al.Whole brain radiation therapy plus stereotactic radiosurgery in the treatment of brain metastases leading to improved survival in patients with favorable prognostic factors. Front Oncol, 2019; 9:205.
8.
MulvennaP, NankivellM, BartonR, et al.Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): Results from a phase 3, non-inferiority, randomised trial. Lancet, 2016; 388(10055):2004–2014.
9.
VenurVA, ChukwuekeUN, LeeEQ. Advances in management of brain and leptomeningeal metastases. Curr Neurol Neurosci Rep, 2020; 20(7):26.
10.
BrownPD, GondiV, PughS, et al.Hippocampal avoidance during whole-brain radiotherapy plus memantine for patients with brain metastases: Phase III Trial NRG Oncology CC001. J Clin Oncol, 2020; 38(10):1019–1029.
11.
BrownPD, PughS, LaackNN, et al.Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: A randomized, double-blind, placebo-controlled trial. Neuro Oncol, 2013; 15(10):1429–1437.
12.
ChilukuriS, BurelaN. Memantine for prevention of brain irradiation-induced cognitive toxicity: A tale of an underappreciated and underused intervention. JCO Glob Oncol, 2020; 6:1384–1388.
13.
YangWC, ChenYF, YangCC, et al.Hippocampal avoidance whole-brain radiotherapy without memantine in preserving neurocognitive function for brain metastases: A phase II blinded randomized trial [published correction appears in Neuro Oncol August 7, 2021]. Neuro Oncol, 2021; 23(3):478–486.
